Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

NCT05765305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-03-15

No results posted yet for this study

Summary

Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Letrozole with chromium

Letrozole versus letrozole with chromium

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-10-01
Completion
2019-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05765305 on ClinicalTrials.gov